Insider Transactions in Q4 2021 at Tarsus Pharmaceuticals, Inc. (TARS)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2021
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
5,833
-0.12%
|
$145,825
$25.31 P/Share
|
|
Dec 01
2021
|
Michael Ackermann Director |
SELL
Open market or private sale
|
Direct |
5,833
-0.12%
|
$145,825
$25.26 P/Share
|
|
Nov 11
2021
|
William J Phd Link |
BUY
Other acquisition or disposition
|
Indirect |
4,348
+50.0%
|
-
|
|
Nov 11
2021
|
William J Phd Link |
SELL
Other acquisition or disposition
|
Indirect |
250,000
-22.48%
|
-
|
|
Nov 08
2021
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,889
-3.63%
|
$52,892
$28.11 P/Share
|
|
Nov 05
2021
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
11
-0.02%
|
$308
$28.11 P/Share
|
|
Nov 04
2021
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
100
-0.19%
|
$2,800
$28.03 P/Share
|
|
Nov 02
2021
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,000
-5.2%
|
$156,000
$26.91 P/Share
|
|
Nov 01
2021
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
5,833
-0.24%
|
$157,491
$27.99 P/Share
|
|
Nov 01
2021
|
Michael Ackermann Director |
SELL
Open market or private sale
|
Direct |
5,833
-0.24%
|
$157,491
$27.97 P/Share
|
|
Oct 12
2021
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
5,531
-0.23%
|
$138,275
$25.97 P/Share
|
|
Oct 12
2021
|
Michael Ackermann Director |
SELL
Open market or private sale
|
Direct |
5,633
-0.23%
|
$146,458
$26.01 P/Share
|
|
Oct 08
2021
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
302
-0.02%
|
$7,550
$25.02 P/Share
|
|
Oct 08
2021
|
Michael Ackermann Director |
SELL
Open market or private sale
|
Direct |
200
-0.02%
|
$5,000
$25.03 P/Share
|